REPORTS

Let’s Pullulate and Expand Your Business

Cardiac Biomarker Market - Global Professional Analysis and Forecast to 2026

Oct 26, 2019  |  174 PAGES  |  REPORT CODE: CMM224960
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Cardiac Biomarker market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period.

This report presents the market size and development trends by detailing the Cardiac Biomarker market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cardiac Biomarker market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cardiac Biomarker industry and will help you to build a panoramic view of the industrial development.

Cardiac Biomarker Market, By Type:

  • Creatine kinase (CK) MB

  • Troponin (cTnI and cTnT)

  • BNP & NT-proBNP

  • Myogloblin

  • Ischemia Modified Albumin (IMA)

  • Others (hs-CRP, D-Dimer, etc.)

Cardiac Biomarker Market, By Application:

  • Myocardial Infarction

  • Congestive Heart Failure

  • Acute Coronary Syndrome

  • Atherosclerosis

  • Others

Some of the leading players are as follows:

  • DiaDexus

  • Abbott Laboratories

  • Alere

  • Response Biomedical

  • Randox Laboratories

  • Singulex

  • BG Medicine

  • Bio-Rad Laboratories

  • Biomerieux

  • Thermo Scientific

  • Roche Diagnostics

  • Siemens Healthcare

  • Beckman Coulter

  • Critical Diagnostics

  • Becton

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Cardiac Biomarker Market: Technology Type Analysis

  • 4.1 Cardiac Biomarker Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Cardiac Biomarker Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Creatine kinase (CK) MB

    • 4.3.2 Troponin (cTnI and cTnT)

    • 4.3.3 BNP & NT-proBNP

    • 4.3.4 Myogloblin

    • 4.3.5 Ischemia Modified Albumin (IMA)

    • 4.3.6 Others (hs-CRP, D-Dimer, etc.)

5 Cardiac Biomarker Market: Product Analysis

  • 5.1 Cardiac Biomarker Product Market Share Analysis, 2018 & 2026

  • 5.2 Cardiac Biomarker Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Cardiac Biomarker Market: Application Analysis

  • 6.1 Cardiac Biomarker Application Market Share Analysis, 2018 & 2026

  • 6.2 Cardiac Biomarker Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Myocardial Infarction

    • 6.3.2 Congestive Heart Failure

    • 6.3.3 Acute Coronary Syndrome

    • 6.3.4 Atherosclerosis

    • 6.3.5 Others

7 Cardiac Biomarker Market: Regional Analysis

  • 7.1 Cardiac Biomarker Regional Market Share Analysis, 2018 & 2026

  • 7.2 Cardiac Biomarker Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 DiaDexus

    • 9.1.1 DiaDexus Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Abbott Laboratories

    • 9.2.1 Abbott Laboratories Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Alere

    • 9.3.1 Alere Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Response Biomedical

    • 9.4.1 Response Biomedical Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Randox Laboratories

    • 9.5.1 Randox Laboratories Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Singulex

    • 9.6.1 Singulex Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 BG Medicine

    • 9.7.1 BG Medicine Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bio-Rad Laboratories

    • 9.8.1 Bio-Rad Laboratories Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Biomerieux

    • 9.9.1 Biomerieux Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Thermo Scientific

    • 9.10.1 Thermo Scientific Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Roche Diagnostics

    • 9.11.1 Roche Diagnostics Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Siemens Healthcare

    • 9.12.1 Siemens Healthcare Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Beckman Coulter

    • 9.13.1 Beckman Coulter Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Critical Diagnostics

    • 9.14.1 Critical Diagnostics Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Becton

    • 9.15.1 Becton Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 100 Figures and 140 Tables)

  • Figure Creatine kinase (CK) MB Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure Troponin (cTnI and cTnT) Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure BNP & NT-proBNP Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure Myogloblin Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure Ischemia Modified Albumin (IMA) Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure Others (hs-CRP, D-Dimer, etc.) Cardiac Biomarker market, 2015 - 2026 (USD Million)

  • Figure Myocardial Infarction market, 2015 - 2026 (USD Million)

  • Figure Congestive Heart Failure market, 2015 - 2026 (USD Million)

  • Figure Acute Coronary Syndrome market, 2015 - 2026 (USD Million)

  • Figure Atherosclerosis market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Cardiac Biomarker market, by country, 2015 - 2026 (USD Million)

  • Table North America Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table North America Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table North America Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Canada Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Canada Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Biomarker market, by country, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Europe Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Germany Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Germany Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table France Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table France Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Italy Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Italy Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Spain Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Spain Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Biomarker market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table China Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table China Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Japan Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Japan Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table India Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table India Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Biomarker market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Biomarker market, by country, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table MEA Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Cardiac Biomarker market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Cardiac Biomarker market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Cardiac Biomarker market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table DiaDexus Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alere Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Response Biomedical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Randox Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Singulex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BG Medicine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomerieux Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Critical Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Becton Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top